These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17553361)
21. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer. Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598 [TBL] [Abstract][Full Text] [Related]
22. Prostate cancer risk assessment program: a 10-year update of cancer detection. Giri VN; Beebe-Dimmer J; Buyyounouski M; Konski A; Feigenberg SJ; Uzzo RG; Hanks G; Godwin AK; Chen DY; Gordon R; Cescon T; Raysor S; Watkins-Bruner D J Urol; 2007 Nov; 178(5):1920-4; discussion 1924. PubMed ID: 17868726 [TBL] [Abstract][Full Text] [Related]
23. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Etzioni R; Gulati R; Falcon S; Penson DF Med Decis Making; 2008; 28(3):323-31. PubMed ID: 18319508 [TBL] [Abstract][Full Text] [Related]
25. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Alcaraz A; Hammerer P; Tubaro A; Schröder FH; Castro R Eur Urol; 2009 Apr; 55(4):864-73. PubMed ID: 19027219 [TBL] [Abstract][Full Text] [Related]
26. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia. Ambrosini GL; Fritschi L; de Klerk NH; Mackerras D; Leavy J Ann Epidemiol; 2008 May; 18(5):364-70. PubMed ID: 18261927 [TBL] [Abstract][Full Text] [Related]
28. Explaining the race difference in prostate cancer stage at diagnosis. Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446 [TBL] [Abstract][Full Text] [Related]
29. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z; Liu J; Li S; Shen W Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463 [TBL] [Abstract][Full Text] [Related]
30. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer. Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941 [TBL] [Abstract][Full Text] [Related]
31. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century. McGrath KG Med Hypotheses; 2009 Jun; 72(6):665-74. PubMed ID: 19307063 [TBL] [Abstract][Full Text] [Related]
32. Issues faced by unaffected men with a family history of prostate cancer: a multidisciplinary overview. Wakefield CE; Meiser B; Gaff CL; Barratt A; Patel MI; Suthers G; Lobb EA; Ramsay J; Mann GJ J Urol; 2008 Jul; 180(1):38-46; discussion 46. PubMed ID: 18485397 [TBL] [Abstract][Full Text] [Related]
33. Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Qin LQ; Xu JY; Wang PY; Tong J; Hoshi K Asia Pac J Clin Nutr; 2007; 16(3):467-76. PubMed ID: 17704029 [TBL] [Abstract][Full Text] [Related]
34. Height, urban-born and prostate cancer risk in Japanese men. Minami Y; Tochigi T; Kawamura S; Tateno H; Hoshi S; Nishino Y; Kuwahara M Jpn J Clin Oncol; 2008 Mar; 38(3):205-13. PubMed ID: 18272473 [TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of prostate cancer risk in candidates for inguinal hernia repair. Thomas AA; Rosenblatt S; Wachterman J; Liao W; Moussa A; Ponsky LE; Jones JS J Am Coll Surg; 2009 Sep; 209(3):371-6. PubMed ID: 19717042 [TBL] [Abstract][Full Text] [Related]
37. Prostate cancer: genes, environment, immunity and the use of immunotherapy. Karan D; Thrasher JB; Lubaroff D Prostate Cancer Prostatic Dis; 2008; 11(3):230-6. PubMed ID: 18283297 [TBL] [Abstract][Full Text] [Related]
38. Alcohol use and prostate cancer: a meta-analysis. Middleton Fillmore K; Chikritzhs T; Stockwell T; Bostrom A; Pascal R Mol Nutr Food Res; 2009 Feb; 53(2):240-55. PubMed ID: 19156715 [TBL] [Abstract][Full Text] [Related]
39. [Epidemiological aspects of benign prostatic hypertrophy]. Valenti M; Necozione S; Di Orio F J Urol (Paris); 1993; 99(6):283-7. PubMed ID: 7516367 [No Abstract] [Full Text] [Related]
40. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Shaik AP; Jamil K; Das P Urol J; 2009; 6(2):78-86. PubMed ID: 19472123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]